Tong Ren Tang Technologies : ANNOUNCEMENT ON RESULTS OF SUBSIDIARY

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

（Stock Code: 1666）

ANNOUNCEMENT ON RESULTS OF SUBSIDIARY

Reference is made to the announcement (the "Announcement") dated 13 August 2020 published by Beijing Tong Ren Tang Chinese Medicine Company Limited ("Tong Ren Tang Chinese Medicine"), a subsidiary of Tong Ren Tang Technologies Co. Ltd. (the "Company") whose shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited (stock code: 3613), in relation to the interim results of Tong Ren Tang Chinese Medicine and its subsidiaries for the six months ended 30 June 2020.

This announcement is made pursuant to Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

The board of directors of the Company would like to draw the attention of its shareholders and the public investors to the following unaudited financial information of Tong Ren Tang Chinese Medicine and its subsidiaries for the six months ended 30 June 2020 as set out in the Announcement.

1

CONDENSED CONSOLIDATED INCOME STATEMENT

2

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

3

CONDENSED CONSOLIDATED BALANCE SHEET

4

CONDENSED CONSOLIDATED BALANCE SHEET (CONTINUED)

5

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

6

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

7

By order of the Board

Tong Ren Tang Technologies Co. Ltd.

Gu Hai Ou

Chairman of the Board

Beijing, the PRC

13 August 2020

As at the date of this announcement, the Board comprises Mr. Gu Hai Ou, Mr. Jin Tao, Mr. Ma Guan Yu, Ms. Wu Qian, Mr. Wang Yu Wei and Ms. Fang Jia Zhi as executive Directors, Mr. Ting Leung Huel, Stephen, Ms. Chan Ching Har, Eliza and Mr. Zhan Yuan Jing as independent non-executive Directors.

8